MedPath

A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat

Not Applicable
Conditions
Male lower urinary tract symptoms with overactive bladder
Registration Number
JPRN-UMIN000002782
Lead Sponsor
Oita University Faculty of Medicine,Department of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients taking medications considered likely to affect micturition 2. PSA>10ng/ml, Patients who suspected prostate cancer 3. Patients who suspected neurogenic bladder 4. Patients with urethral stricture 5. Patients with chronic prostatitis or active urinary tract infenction 6. Patients with previous surgery for BPH 7.Patients with previous intrapelvic radiation 8. Complications considered likely to affect micturition(bladder neck constriction,bladder calculus,urinary calculus, cerebrovascular disease etc). 9. Patients with severe hepatic disorders,severe renal dysfunction and severe cardiovascular disease 10. Patients with performing intermittent catheter insertion themselves 11. Patients with orthostatic hypotension 12.Patients taking OTC medication and dietary supplement considered likely to affect micturition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate by using Questionnaires for urinary symptoms(IPSS and OABSS) at 4,8 and 12 weeks.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath